tiprankstipranks
Silence Therapeutics (SLN)
NASDAQ:SLN
US Market
SLN
Silence Therapeutics
RESEARCH TOOLSreports
Want to see SLN full AI Analyst Report?

Silence Therapeutics (SLN) Income Statement

355 Followers

Silence Therapeutics Income Statement

Last quarter (Q1 2026), Silence Therapeutics's total revenue was £421.29K, an increase of 196.68% from the same quarter last year. In Q1, Silence Therapeutics's net income was £-14.93M. See Silence Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
£ 559.00K£ 43.26M£ 25.38M£ 17.65M£ 12.41M
Gross Profit
£ 344.00K£ 31.45M£ 15.06M£ 6.68M£ 4.96M
Operating Expenses
£ 90.10M£ 94.77M£ 64.66M£ 56.44M£ 50.77M
Depreciation and Amortization
£ 555.00K£ 593.00K£ 498.00K£ 485.86K£ 427.00K
EBITDA
£ -89.20M£ -48.99M£ -49.78M£ -49.27M£ -45.42M
Operating Income
£ -89.75M£ -63.32M£ -49.60M£ -49.76M£ -45.81M
Other Income/Expenses
£ 1.15M£ 18.86M£ -706.00K£ 9.29M£ -42.00K
Pretax Income
£ -88.60M£ -44.46M£ -50.31M£ -40.47M£ -45.86M
Net Income
£ -88.61M£ -45.31M£ -43.27M£ -41.03M£ -39.41M
Per Share Metrics
Basic EPS
£ -1.89£ -2.37£ -3.48£ -3.78£ -1.35
Diluted EPS
£ -1.89£ -2.37£ -3.48£ -3.78£ -1.35
Weighted Average Shares Outstanding
 47.23M 15.42M 12.36M 10.73M 29.65M
Weighted Average Shares Outstanding (Diluted)
 47.23M 15.42M 12.36M 10.73M 29.65M
Currency in GBP

Silence Therapeutics Earnings and Revenue History